To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024.
Source: Congress.gov ·
252 words in original text
What This Bill Does
This bill limits how much money can be spent on the FDA Innovation Account, which is part of the Cures Act (a previous law that gave the FDA special funding). The bill says that for fiscal year 2024, the total amount of money available for this account cannot go over a specific amount.
Who It Affects
The Food and Drug Administration and any Related Agency that receives funds from the FDA Innovation Account, Cures Act.
Key Provisions
• The total amount of money that can be used for the Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024 may not exceed $50,000,000 (Sec. 1)
What Changes
If this bill becomes law, spending on the FDA Innovation Account, Cures Act would be capped at $50,000,000 for fiscal year 2024. Any money authorized or otherwise available for this account beyond that amount would not be allowed to be spent.
Important Definitions
None defined in bill text.
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.